doi: 10.1128/AAC.48.9.3556-3558.2004.
SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease
Affiliations
- PMID: 15328125
- PMCID: PMC514788
- DOI: 10.1128/AAC.48.9.3556-3558.2004
Item in Clipboard
SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease
Antimicrob Agents Chemother.
2004 Sep.
Abstract
Treatment of Mycobacterium avium disease remains challenging when macrolide resistance develops. We infected C57 beige mice and treated them with mefloquine, SRI-286, and moxifloxacin. SRI-286 (80 mg/kg) was bactericidal in the liver. Mefloquine plus moxifloxacin or mefloquine plus SRI-286 were better than mefloquine alone.
Similar articles
-
Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice.Antimicrob Agents Chemother. 2003 Aug;47(8):2685-7. doi: 10.1128/AAC.47.8.2685-2687.2003. Antimicrob Agents Chemother. 2003. PMID: 12878542 Free PMC article.
-
Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.J Infect Dis. 2003 Jun 15;187(12):1977-80. doi: 10.1086/375352. Epub 2003 Jun 4. J Infect Dis. 2003. PMID: 12792877
-
Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.Antimicrob Agents Chemother. 2001 Jan;45(1):217-22. doi: 10.1128/AAC.45.1.217-222.2001. Antimicrob Agents Chemother. 2001. PMID: 11120969 Free PMC article.
-
Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium.Future Microbiol. 2011 Apr;6(4):433-9. doi: 10.2217/fmb.11.25. Future Microbiol. 2011. PMID: 21526944 Review.
-
[Moxifloxacin (Kanavig), ophthalmic administration].J Pharm Belg. 2012 Jun;(2):41-2. J Pharm Belg. 2012. PMID: 22978015 Review. French. No abstract available.
Cited by
-
Nicotinaldehyde [2,8-bis-(trifluoro-meth-yl)quinolin-4-yl]hydrazone monohydrate.Acta Crystallogr Sect E Struct Rep Online. 2010 Aug 11;66(Pt 9):o2237-8. doi: 10.1107/S1600536810030862. Acta Crystallogr Sect E Struct Rep Online. 2010. PMID: 21588605 Free PMC article.
-
Progress in the study of mefloquine as an antibiotic adjuvant for combination bacterial inhibition treatment.Front Cell Infect Microbiol. 2024 Nov 28;14:1470891. doi: 10.3389/fcimb.2024.1470891. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39669268 Free PMC article. Review.
-
Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria.PLoS One. 2007 Dec 19;2(12):e1343. doi: 10.1371/journal.pone.0001343. PLoS One. 2007. PMID: 18094751 Free PMC article.
-
Novel Organic Salts Based on Mefloquine: Synthesis, Solubility, Permeability, and In Vitro Activity against Mycobacterium tuberculosis.Molecules. 2022 Aug 13;27(16):5167. doi: 10.3390/molecules27165167. Molecules. 2022. PMID: 36014405 Free PMC article.
-
Synthesis, anti-mycobacterial and cytotoxic evaluation of substituted isoindoline-1,3-dione-4-aminoquinolines coupled via alkyl/amide linkers.RSC Adv. 2019 Mar 13;9(15):8515-8528. doi: 10.1039/c8ra10532d. eCollection 2019 Mar 12. RSC Adv. 2019. PMID: 35518673 Free PMC article.
References
-
- Bermudez, L. E., C. B. Inderlied, P. Kolonoski, M. Petrofsky, P. Aralar, M. Wu, and L. S. Young. 2001. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. Antimicrob. Agents Chemother. 45:217-222. - PMC - PubMed
-
- Bermudez, L. E., P. Kolonoski, M. Petrofsky, M. Wu, C. B. Inderlied, and L. S. Young. 2003. Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease. J. Infect. Dis. 187:1977-1980. - PubMed
-
- Chaisson, R. E., C. A. Benson, M. P. Dube, L. B. Heifets, J. A. Korvick, S. Elkin, T. Smith, J. C. Craft, and F. R. Sattler. 1994. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. Ann. Intern. Med. 121:905-911. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
